Latest news
Latigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 17:52:10 GMTFriday Five – The short-lived story of BristolZeneca...and more from a busy week in biopharma - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 14:56:57 GMTAstraZeneca-BMS merger rumours hit dead end: report - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 14:06:57 GMTRoche-backed Mironid gets $46M boost to put rare kidney disease drug on path to clinic - FirstWord PharmaFirstWord Pharma · Wed, 05 Aug 2026 08:06:57 GMTAstraZeneca, BMS reportedly in $400B merger talks - FirstWord PharmaFirstWord Pharma · Mon, 03 Aug 2026 04:16:55 GMT